Seelos Therapeutics Announces Data Demonstrating Statistically Significant Downregulation of mRNA and Reduction of Alpha Synuclein in an In Vitro Gene Therapy Study of SLS-004 Utilizing CRISPR-dCas9 in Dementia with Lewy Bodies June 9, 2022 Read More »
UTSA awards $4 million to Oskar Fischer Prize recipients for innovative explanations of Alzheimer’s disease June 8, 2022 Read More »
The Impact of T Cells in Neurodegenerative Disease and Regenerative Therapies June 6, 2022 Read More »
Biorep Technologies, Inc. Joins the Tetra Partner Network to Accelerate Research into Stem-Cell Derived Insulin to Cure Diabetes May 31, 2022 Read More »
